Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003

American Journal of Epidemiology

Volumn 169, Issue 1, 2009, Pages 33-40

  Engel, Stephanie M ^a   Janevic, Teresa M ^b   Stein, Cheryl R ^a   Savitz, David A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

Birth weight; Pre eclampsia; Preterm birth; Smoking

Indexed keywords

DISEASE; HYPERTENSION; SMOKING; WOMENS HEALTH;

AGED; ARTICLE; BIRTH WEIGHT; CHRONIC DISEASE; DELIVERY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FETUS OUTCOME; HUMAN; HYPERTENSION; INFANT; INFANT WELFARE; MATERNAL HYPERTENSION; MATERNAL SMOKING; MATERNAL WELFARE; PATIENT SELECTION; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PROTECTION; PUBLIC HEALTH; RISK; UNITED STATES;

ADULT; BIRTH WEIGHT; CONFIDENCE INTERVALS; FEMALE; FETAL GROWTH RETARDATION; HEALTH STATUS; HUMANS; INFANT, NEWBORN; MIDDLE AGED; MOTHERS; NEW YORK CITY; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; SMOKING;

NEW YORK [NEW YORK (STT)]; NEW YORK [UNITED STATES]; NORTH AMERICA; UNITED STATES;

EID: 58149235029     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn293     Document Type: Article

References (45)

1. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102(1):181-192.
2. Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006;195(6):1557-1563.
3. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response - a review. Placenta. 2003;24(suppl A):S21-S27.
4. Hammoud AO, Bujold E, Sorokin Y, et al. Smoking in pregnancy revisited: findings from a large population-based study. Am J Obstet Gynecol. 2005;192(6):1856-1862; discussion 1862-1863.
5. Ananth CV, Cnattingius S. Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden. Am J Epidemiol. 2007;166(3):289-295.
6. Macmahon B, Alpert M, Salber EJ. Infant weight and parental smoking habits. Am J Epidemiol. 1965;82(3):247-261.
7. Butler NR, Goldstein H, Ross EM. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J. 1972;2(5806):127-130.
8. Horta BL, Victora CG, Menezes AM, et al. Low birthweight, preterm births and intrauterine growth retardation in relation to maternal smoking. Paediatr Perinat Epidemiol. 1997;11(2):140-151.
9. Meyer MB, Jonas BS, Tonascia JA. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol. 1976;103(5):464-476.
10. Sprauve ME, Lindsay MK, Drews-Botsch CD, et al. Racial patterns in the effects of tobacco use on fetal growth. Am J Obstet Gynecol. 1999;181(1):S22-S27.
11. Conde-Agudelo A, Althabe F, Belizan JM, et al. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181(4):1026-1035.
12. Manson JE, Ajani UA, Liu S, et al. A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians. Am J Med. 2000;109(7):538-542.
13. Cnattingius S, Mills JL, Yuen J, et al. The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol. 1997;177(1):156-161.
14. Newman MG, Lindsay MK, Graves W. Cigarette smoking and pre-eclampsia: their association and effects on clinical outcomes. J Matern Fetal Med. 2001;10(3):166-170.
15. Xiao R, Sorensen TK, Williams MA, et al. Influence of preeclampsia on fetal growth. J Matern Fetal Neonatal Med. 2003;13(3):157-162.
16. Marcoux S, Brisson J, Fabia J. The effect of cigarette smoking on the risk of preeclampsia and gestational hypertension. Am J Epidemiol. 1989;130(5):950-957.
17. Odegard RA, Vatten LJ, Nilsen ST, et al. Preeclampsia and fetal growth. Obstet Gynecol. 2000;96(6):950-955.
18. Beste LA, England LJ, Schisterman EF, et al. Pregnancy outcomes in smokers who develop pre-eclampsia. Paediatr Perinat Epidemiol. 2005;19(1):12-18.
19. Savitz DA, Janevic TM, Engel SM, et al. Ethnicity and gestational diabetes in New York City, 1995-2003. BJOG. 2008;115(8):969-978.
20. Lydon-Rochelle MT, Holt VL, Cárdenas V, et al. The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol. 2005;193(1):125-134.
21. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology. 1992;3(5):452-456.
22. Geller SE, Ahmed S, Brown ML, et al. International Classification of Diseases-9th revision coding for preeclampsia: how accurate is it? Am J Obstet Gynecol. 2004;190(6):1629-1633; discussion 1633-1634.
23. Rothman KJ, Greenland S, eds. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven; 1998.
24. Bodnar LM, Catov JM, Klebanoff MA, et al. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18(2):234-239.
25. Catov JM, Ness RB, Kip KE, et al. Risk of early or severe preeclampsia related to pre-existing conditions. Int J Epidemiol. 2007;36(2):412-419.
26. Honein MA, Paulozzi LJ, Watkins ML. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public Health Rep. 2001;116(4):327-335.
27. Perreira KM, Cortes KE. Race/ethnicity and nativity differences in alcohol and tobacco use during pregnancy. Am J Public Health. 2006;96(9):1629-1636.
28. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol. 1990;132(4):746-748.
29. Bainbridge SA, Sidle EH, Smith GN. Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses. 2005;64(1):17-27.
30. Bainbridge SA, Belkacemi L, Dickinson M, et al. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Am J Pathol. 2006;169(3):774-783.
31. Bilban M, Bach FH, Otterbein SL, et al. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity. 2006;24(5):601-610.
32. Chin BY, Jiang G, Wegiel B, et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A. 2007;104(12):5109-5114.
33. Nakao A, Choi AM, Murase N. Protective effect of carbon monoxide in transplantation. J Cell Mol Med. 2006;10(3):650-671.
34. Wang X, Wang Y, Kim HP, et al. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem. 2007;282(3):1718-1726.
35. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6(4):422-428.
36. Zhang F, Kaide JI, Rodriguez-Mulero F, et al. Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am J Hypertens. 2001;14(6 pt 2):62S-67S.
37. Fujita T, Toda K, Karimova A, et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med. 2001;7(5):598-604.
38. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med. 2000;192(7):1015-1026.
39. Liu XM, Chapman GB, Peyton KJ, et al. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res. 2002;55(2):396-405.
40. Powers RW, Roberts JM, Cooper KM, et al. Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia. Am J Obstet Gynecol. 2005;193(1):185-191.
41. Cudmore M, Ahmad S, Al-Ani B, et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation. 2007;115(13):1789-1797.
42. Joseph KS. The fetuses-at-risk approach: clarification of semantic and conceptual misapprehension. BMC Pregnancy Childbirth. 2008;8:11.
43. Joseph KS. Incidence-based measures of birth, growth restriction, and death can free perinatal epidemiology from erroneous concepts of risk. J Clin Epidemiol. 2004;57(9):889-897.
44. Joseph KS. Theory of obstetrics: the fetuses-at-risk approach as a causal paradigm. J Obstet Gynaecol Can. 2004;26(11):953-960.
45. Joseph KS, Allen AC, Lutfi S, et al. Does the risk of cerebral palsy increase or decrease with increasing gestational age? BMC Pregnancy Childbirth. 2003;3(1):8.